Abdulrahman A. Almehizia, PhD, is a distinguished Professor of Medicinal Chemistry at King Saud University, Riyadh, Saudi Arabia. With a robust academic background and extensive experience in pharmaceutical sciences, Dr. Almehizia has made significant contributions to teaching, research, and leadership within the Department of Pharmaceutical Chemistry. His career includes pivotal roles such as Department Chair and Chairman of the Drug Exploration and Development Chair (DEDC). He holds a PhD in Pharmaceutical Sciences from the University of Pittsburgh and continues to shape the field through innovative research and academic mentorship.
Author Metrics
ORCID Profile
Google Scholar Profile
Scopus Profile
Dr. Almehizia’s impact in academia is underscored by his substantial author metrics. He maintains a notable h-index of 24 on Scopus and has an active presence on Google Scholar with a comprehensive profile of citations. His research output is documented through numerous publications in high-impact journals and several patents in medicinal chemistry and biotechnology.
- Citations: 2149
- h-index: 27
- i10-index: 57
Education
Abdulrahman A. Almehizia completed his Bachelor of Science in Pharmaceutical Sciences at King Saud University, Riyadh, Saudi Arabia, in 2007. He pursued advanced studies in the United States, earning his Doctor of Philosophy (PhD) in Pharmaceutical Sciences with a focus on Medicinal Chemistry and Biotechnology from the University of Pittsburgh in 2015.
Research Focus
Dr. Almehizia’s research focuses on the intersection of medicinal chemistry, biotechnology, and drug development. His work spans the synthesis and characterization of novel therapeutic compounds, drug delivery systems, and the application of computational methods in pharmaceutical sciences. He is particularly interested in addressing healthcare challenges through innovative drug discovery and development approaches.
Professional Journey
Dr. Almehizia’s professional journey at King Saud University began in 2006 as a Teaching Assistant and has progressed through various academic ranks, including Assistant Professor, Associate Professor, and Professor in the Department of Pharmaceutical Chemistry. He has also served as Department Chair and currently holds the position of Chairman of the Drug Exploration and Development Chair (DEDC).
Honors & Awards
Throughout his career, Dr. Almehizia has received recognition for his academic and research contributions. He was awarded a Graduate Scholarship from King Saud University and has been honored with a Travel and Presenter Award for his participation in international scientific conferences. His achievements reflect his commitment to excellence in pharmaceutical sciences.
Publications Noted & Contributions
Dr. Almehizia’s research output includes a prolific list of publications in peer-reviewed journals, showcasing his expertise in medicinal chemistry, drug discovery, and biotechnology. His contributions extend to multiple patents, demonstrating innovation in the development of therapeutic agents and drug delivery systems.
Copper–Vit B3 MOF preparation, characterization and catalytic evaluation in a one-pot synthesis of benzoxanthenones with docking validation as anti H. pylori
Journal: RSC Advances, 2024
DOI: 10.1039/D4RA03468F
Contributors: Asma S. Al-Wasidi, Mahmoud Tarek, Gehad E. Said, Ahmed M. Naglah, Abdulrahman A. Almehizia, Tamer K. Khatab
Summary: This study focuses on the preparation and characterization of a Copper–Vitamin B3 Metal-Organic Framework (MOF) and its catalytic performance in the synthesis of benzoxanthenones. The research includes computational docking studies validating its potential as an anti-Helicobacter pylori agent.
In vitro biological studies and computational prediction-based analyses of pyrazolo[1,5-a]pyrimidine derivatives
Journal: RSC Advances, 2024
DOI: 10.1039/D4RA00423J
Contributors: Abdulrahman A. Almehizia, Wael M. Aboulthana, Ahmed M. Naglah, Ashraf S. Hassan
Summary: This article explores the biological activities of pyrazolo[1,5-a]pyrimidine derivatives through in vitro studies and computational predictions. It emphasizes the potential of these derivatives as pharmacologically active compounds.
Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents
Journal: Journal of Molecular Structure, 2024
DOI: 10.1016/j.molstruc.2024.138301
Contributors: Shahid Ayaz, Shankar Gupta, Rajveer Singh, Balak Das Kurmi, Abdulrahman A. Almehizia, Vivek Asati
Summary: Published in the Journal of Molecular Structure, this research integrates computational and synthetic approaches to develop pyrazolo-pyridine derivatives with potential anticancer properties, highlighting a multidisciplinary approach to drug discovery.
Niacin based MOF as efficient nano-catalyst in the synthesis of some new benzothiazoles and benzimidazoles as anti-Alzheimer (AChE inhibitors)
Journal: Journal of Molecular Structure, 2024
DOI: 10.1016/j.molstruc.2024.138462
Contributors: Gehad E. Said, Mahmoud Tarek, Asma S. Al-Wasidi, Ahmed M. Naglah, Abdulrahman A. Almehizia, Tamer K. Khatab
Summary: This study investigates the use of a niacin-based Metal-Organic Framework (MOF) as a nano-catalyst in the synthesis of benzothiazoles and benzimidazoles, focusing on their potential as anti-Alzheimer agents by inhibiting Acetylcholinesterase (AChE).
Determination of nanoparticle solubility through green nanonization process using machine learning approach: Computational modeling and optimization
Journal: Ain Shams Engineering Journal, 2024
DOI: 10.1016/j.asej.2024.102946
Contributors: Ahmad J. Obaidullah, Abdulrahman A. Almehizia
Summary: Published in the Ain Shams Engineering Journal, this research employs a machine learning approach for computational modeling and optimization of nanoparticle solubility, showcasing innovative techniques in nanotechnology.
Research Timeline
Over the years, Dr. Almehizia has established a comprehensive research timeline marked by significant milestones. Starting with his doctoral studies at the University of Pittsburgh, his research trajectory has evolved through various academic and leadership roles at King Saud University, where he continues to spearhead impactful projects in pharmaceutical sciences.
Collaborations and Projects
Dr. Almehizia actively collaborates with national and international researchers, fostering partnerships that enhance research outcomes and expand scientific knowledge in medicinal chemistry and biotechnology. His involvement in collaborative projects underscores his commitment to advancing pharmaceutical research on a global scale.
This structured overview provides a detailed portrait of Dr. Abdulrahman A. Almehizia’s academic journey, research contributions, and professional impact in the field of medicinal chemistry and pharmaceutical sciences.